Treatment of chronic dry eye: focus on cyclosporine

References

• AfonsoAMonroyDSternM1999Correlation of tear fluorescein clearance and Schirmer test scores with ocular irritation symptomsOphthalmology1068031010201606
   PubMed Web of Science ®Google Scholar
• AfonsoASobrinLMonroyD1999Tear fluid pro-gelatinase B activity correlates with tear clearance and IL-1 concentration in patients with ocular rosaceaInvest Ophthalmol Vis Sci4025061210509643
   PubMed Web of Science ®Google Scholar
• AkpekEKDartJKWatsonS2004A randomized trial of topical cyclosporine 0.05% in topical steroid-resistant atopic keratoconjunctivitisOphthalmology1114768215019322
   PubMed Web of Science ®Google Scholar
• AkpekEKMerchantAPinarV1997Ocular rosacea: patient characteristics and follow-upOphthalmology104186379373118
   PubMed Web of Science ®Google Scholar
• AminARAtturMGThakkerGD1996A novel mechanism of action of tetracyclines: effects on nitric oxide synthasesProc Natl Acad Sci USA9314014198943052
   PubMed Web of Science ®Google Scholar
• ArasCOzdamarABahceciogluH2000Decreased tear secretion after laser in situ keratomileusis for high myopiaJ Refract Surg16362410832986
   PubMed Web of Science ®Google Scholar
• BarberLPflugfelderSTauberJ2005Phase III safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 yearsOphthalmology1121790416102833
   PubMed Web of Science ®Google Scholar
• BattatLMacriADursunD2001Effects of laser in situ keratomileusis on tear production, clearance, and the ocular surfaceOphthalmology1081230511425680
   PubMed Web of Science ®Google Scholar
• BaudouinCBrignoleFBecquetF1997Flow cytometry in impression cytology specimensInvest Ophthalmol Vis Sci381458649191610
   PubMed Web of Science ®Google Scholar
• BehrensADoyleJJSternL2006Dysfuncional tear syndrome. A Delphi approach to treatment recommendationsCornea25900717102664
   PubMed Web of Science ®Google Scholar
• BenEzraDMaftzirGde CourtenC1990Ocular penetration of cyclosporine A. III: The human eyeBr J Ophthalmol7435022378841
   PubMed Web of Science ®Google Scholar
• BjerrumK1997Keratoconjunctivitis sicca and primary Sjogren’s syndrome in a Danish population aged 30–60 yearsActa Ophthalmol Scand7528169253975
   PubMedGoogle Scholar
• BronADaubasPSiou-MermetR1998Comparison of the efficacy and safety of two eye gels in the treatment of dry eyes: Lacrinorm and ViscotearsEye128394710070521
   PubMed Web of Science ®Google Scholar
• GeorganasCIoakimidisDIatrouC1996Relapsing Wegener’s granulomatosis: successful treatment with cyclosporin-AClin Rheumatol15189928777855
   PubMed Web of Science ®Google Scholar
• CleggJGuestJLehmanA2006The annual cost of dry eye syndrome in France, Germany, Italy, Spain, Sweden and the United Kingdom among patients managed by ophthalmologistsOphthalmic Epidemol1326374
   PubMed Web of Science ®Google Scholar
• DEW2007The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye Workshop (2007)Ocul Surf5759217508116
   PubMed Web of Science ®Google Scholar
• Frucht-PeryJSagiEHemoI1993Efficacy of doxycycline and tetracycline in ocular rosaceaAm J Ophthalmol11688928328549
   PubMed Web of Science ®Google Scholar
• GaoJSchwalbTAAddeoJV1998The role of apoptosis in the pathogenesis of canine keratoconjunctivitis sicca: the effect of topical Cyclosporin A therapyCornea17654639820947
   PubMed Web of Science ®Google Scholar
• GiffordPEvansBMorrisJ2006A clinical evaluation of SystaneCont Lens Anterior Eye29314216473547
   PubMedGoogle Scholar
• GunduzKOzdemirO1994Topical cyclosporin treatment of keratoconjunctivitis sicca in secondary Sjogren’s syndromeActa Ophthalmol (Copenh)72438427825408
   PubMed Web of Science ®Google Scholar
• HarmonDMurphyR2003Dry eye market set for robust growthMarket Scope878
   Google Scholar
• HeigleTJPflugfelderSC1996Aqueous tear production in patients with neurotrophic keratitisCornea1513588925660
   PubMed Web of Science ®Google Scholar
• IzciCCelikIAlkanF2002Histologic characteristics and local cellular immunity of the gland of the third eyelid after topical ophthalmic administration of 2% cyclosporine for treatment of dogs with keratoconjunctivitis siccaAm J Vet Res636889412013470
   PubMed Web of Science ®Google Scholar
• JonesDTJiAMonroyD1998Evaluation of ocular surface cytokine, mucin, and cytokeratin expression in Sjogren’s SyndromeAdv Exp Med Biol43853369634933
   PubMed Web of Science ®Google Scholar
• MasudaKNakajimaAUrayamaA1989Double-masked trial of cyclosporin versus colchicine and longterm open study of cyclosporin in Behcet’s diseaseLancet1109362566048
   PubMed Web of Science ®Google Scholar
• KaswanRSalisburyMWardD1989Spontaneous canine keratoconjunctivitis sicca. A useful model for human keratoconjunctivitis sicca: treatment with cyclosporine eye dropsArch Ophthalmol1071210162757551
   PubMed Web of Science ®Google Scholar
• KunertKSTisdaleASGipsonIK2002Goblet cell numbers and epithelial proliferation in the conjunctiva of patients with dry eye syndrome treated with cyclosporineArch Ophthalmol120330711879137
   PubMed Web of Science ®Google Scholar
• LaibovitzRASolchSAndrianaoJ1993Pilot trial of cyclosporine 1% ophthalmic ointment in the treatment of keratoconjunctivitis siccaCornea12315238339560
   PubMed Web of Science ®Google Scholar
• LallemandFFelt-BaeyensOBesseghirK2003Cyclosporine A delivery to the eye: A pharmaceutical challengeEur J Pharm Biopharm563071814602172
   PubMed Web of Science ®Google Scholar
• LempMA1995Report of the National Eye Institute/Industry Workshop on Clinical Trials in Dry EyesCLAO J2122232
   Google Scholar
• LevellNJMunroCSMarksJM1992Severe lichen planus clears with very low dose cyclosporinBr J Dermatol1276671637703
   PubMed Web of Science ®Google Scholar
• LinPTsaiSChengC2003Prevalence of dry eye among an elderly Chinese population in Taiwan: the Shihpai Eye StudyOphthalmology110109610112799232
   PubMed Web of Science ®Google Scholar
• LinnaTUVesaluomaMHPerez-SantonjaJJ2000Effect of myopic LASIK on corneal sensitivity and morphology of subbasal nervesInvest Ophthalmol Vis Sci41393710670467
   PubMed Web of Science ®Google Scholar
• MarshPPflugfelderSC1999Topical non-preserved methylprednisolone therapy of keratoconjunctivitis sicca in Sjogren’s syndromeOphthalmology106811610201607
   PubMed Web of Science ®Google Scholar
• McCartyCBansalALivingstonP1998The epidemiology of dry eye in Melbourne, AustraliaOphthalmology105111499627665
   PubMed Web of Science ®Google Scholar
• MeggsWJ1993Neurogenic inflammation and sensitivity to environmental chemicalsEnviron Health Perspect10123488404760
   PubMed Web of Science ®Google Scholar
• MihatschMKyoMMorozumiK1998The side-effects of ciclosporine-A and tacrolimusClin Nephrol49356639696431
   PubMed Web of Science ®Google Scholar
• MiljatovicBDanaRSullivanD2007Impact of dry eye syndrome on vision-related quality of lifeAm J Ophthalmol1434091517317388
   PubMed Web of Science ®Google Scholar
• MircheffAGierowJPYangT1998Sjogren’s autoimmunity: how perturbation of recognition in endomembrane traffic may provoke pathological recognition at the cell surfaceJ Mol Recognit1140810076804
   PubMed Web of Science ®Google Scholar
• MorganRVAbramsKL1991Topical administration of cyclosporine for treatment of keratoconjunctivitis sicca in dogsJ Am Vet Med Assoc199104361748607
   PubMed Web of Science ®Google Scholar
• NassarallaBAMcLeodSDNassaralaJJJr2003Effect of myopic LASIK on human corneal sensitivityOphthalmology11049750212623811
   PubMed Web of Science ®Google Scholar
• NussenblattRPalestineAChanC1991Randomized, double-masked study of cyclosporine compared to prednisolone in the treatment of endogenous uveitisAm J Ophthalmol112138461867297
   PubMed Web of Science ®Google Scholar
• OliveroDKDavidsonMGEnglishRV1991Clinical evaluation of 1% cyclosporine for topical treatment of keratoconjunctivitis sicca in dogsJ Am Vet Med Assoc1991039421748606
   PubMed Web of Science ®Google Scholar
• OuslerGMichaelsonCChristensenM2007An evaluation of tear film break-up time extension and ocular protection index scores among three marketed lubricant eye dropsCornea269495217721294
   PubMed Web of Science ®Google Scholar
• PerryHDDoshi-CarnevaleSDonnenfeldED2003Topical cyclosporin A 0.5% as a possible new treatment for superior limbic keratoconjunctivitisOphthalmology11015788112917176
   PubMed Web of Science ®Google Scholar
• PflugfelderSJonesDTJiZ1999Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjogren’s syndrome kerato-conjunctivitis siccaCurr Eye Res192011110487957
   PubMed Web of Science ®Google Scholar
• PflugfelderSSolomonASternM2000The diagnosis and management of dry eye. a twenty-five-year reviewCornea19644911009316
   PubMed Web of Science ®Google Scholar
• PflugfelderSCMaskinSLAndersonB2004A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearanceAm J Ophthalmol1384445715364229
   PubMed Web of Science ®Google Scholar
• PflugfelderSC2004Antiinflammatory therapy for dry eyeAm J Ophthalmol1373374214962426
   PubMed Web of Science ®Google Scholar
• PlugfelderSC2006Dry eyeFocal Points (AAO)145
   Google Scholar
• PrummelMMouritsMBerghoutA1989Prednisone and cyclosporine in the treatment of severe Graves’ ophthalmopathyN Engl J Med321135392519530
   PubMed Web of Science ®Google Scholar
• PucciNNovembreECianferoniA2002Efficacy and safety of cyclosporine eyedrops in vernal keratoconjunctivitisAnn Allergy Asthma Immunol8929830312269651
   PubMed Web of Science ®Google Scholar
• RaoSRaoR2006Efficacy of topical cyclosporine 0.05% in the treatment of dry eye associated with graft versus host diseaseCornea25674817077659
   PubMed Web of Science ®Google Scholar
• ReinhardTSundmacherRGodehardtE1997Preventive systemic cyclosporin A after keratoplasty at increased risk for immune reactions as the only elevated risk factorOphthalmologe944965009333395
   PubMed Web of Science ®Google Scholar
• RubinBIHollandEJde SmetMD1991Response of reactivated ligneous conjunctivitis to topical cyclosporinAm J Ophthalmol1129561882932
   PubMed Web of Science ®Google Scholar
• SalibGMcDonaldMSmolekM2006Safety and efficacy of cyclosporine 0.05% drops versus unpreserved artificial tears in dry-eye patients having laser in situ keratomileusisJ Cataract Refract Surg32772816765793
   PubMed Web of Science ®Google Scholar
• SallKCohenSChristensenM2006An evaluation of the efficacy of a Cyclosporine-based dry eye therapy when used with marked artificial tears as a supportive therapy in dry eyeEye Contact Lens3221616415689
   PubMedGoogle Scholar
• SallKStevensonODMundorfTK2000Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye diseaseOphthalmology107631910768324
   PubMed Web of Science ®Google Scholar
• ScheinOMunozBTielschJ1997Prevalence of dry eye among the elderlyAm J Ophthalmology1247238
   PubMed Web of Science ®Google Scholar
• ScheinOMunozBTielschJ1997Prevalence of dry eye among the elderlyAm J Ophthalmol12472389402817
   PubMed Web of Science ®Google Scholar
• ScheinOTielschJMunozB1997Relation between signs and symptoms of dry eye in the elderly: a population-based perspectiveOphthalmology10413954019307632
   PubMed Web of Science ®Google Scholar
• ShlopovBVSmithGNColeAA1999Differential patterns of response to doxycycline and transforming growth factor beta1 in the down-regulation of collagenases in osteoarthritic and normal human chondrocytesArthritis Rheum427192710211886
   PubMed Web of Science ®Google Scholar
• SobrinLLiuZMonroyD2000Activators and inhibitors of matrix metalloproteinase-9 in human tear fluid and corneal epithelial culture supernatantInvest Ophthalmol Vis Sci411703910845589
   PubMed Web of Science ®Google Scholar
• SternMEBeuermanRWFoxRI1998The pathology of dry eye: the interaction between the ocular surface and lacrimal glandsCornea1758499820935
   PubMed Web of Science ®Google Scholar
• StevensonDTauberJReisBL2000Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease a dose-ranging, randomized trialOphthalmology1079677410811092
   PubMed Web of Science ®Google Scholar
• TishlerMYaronIGeyerD1998Elevated tear interleukin-6 levels in patients with Sjogren’s syndromeOphthalmology105232799855167
   PubMed Web of Science ®Google Scholar
• TodaIAsano-KatoNKomai-HoriY2001Dry eye after laser in situ keratomileusisAm J Ophthalmol1321711438046
   PubMed Web of Science ®Google Scholar
• ToshidaHNakayasuKKanaiA1998Effect of Cyclosporin A Eyedrops on Tear Secretion in RabbitJpn J Ophthalmol42168739690893
   PubMed Web of Science ®Google Scholar
• TsubotaKSaitoIIshimaruN1998Use of topical cyclosporin A in a primary Sjogren’s syndrome mouse modelInvest Ophthalmol Vis Sci39155199699544
   PubMed Web of Science ®Google Scholar
• WilsonCZhuYFierM1998Ocular contact time of a carbomer gel (GelTears) in humansBr J Ophthalmol82113149924298
   PubMed Web of Science ®Google Scholar
• YoshidaAFujiharaTNakataK1999Cyclosporine increase tear fluid secretion via release of sensory neurotransmitters and muscarinic pathway in miceExp Eye Res68541610328967
   PubMed Web of Science ®Google Scholar